Status and phase
Conditions
Treatments
About
Many reports argued about the possible beneficial effects of Hydroxychloroquine in treating COVID-19 patients and this study was designed to investigate this claim
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Confirmed cases of SARS-CoV-2 by PCR
Exclusion criteria
less than 18 years old known hypersensitivity to the drug
Primary purpose
Allocation
Interventional model
Masking
200 participants in 2 patient groups
Loading...
Central trial contact
Samah M Lutfy, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal